ClinicalTrials.Veeva

Menu

mNGS Versus Blood Culture in FN

P

Peking University

Status

Unknown

Conditions

Febrile Neutropenia
Infections
Hematologic Diseases

Treatments

Diagnostic Test: blood culture versus mNGS detection

Study type

Observational

Funder types

Other

Identifiers

NCT05149547
mNGS for FN(2021PHB362-001)

Details and patient eligibility

About

Blood stream infection (BSI) during febrile neutropenia (FN) is a lethal complication, while confirmed diagnosis via blood culture is usually with low sensitivity and time delay. The new technique of metagenome next generation sequencing (mNGS) has the potential of early and more accurate detection of pathogens. However, this technique has not been well validated for BSI diagnosis in patients with hematological disease. Therefore, we designed a prospective multicenter study to compare the diagnosis performance in BSI.

Enrollment

300 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hematologic disease
  • febrile neutropenia

Exclusion criteria

  • refuse to consent
  • age<=14
  • not caused by infection

Trial contacts and locations

1

Loading...

Central trial contact

Yuqian Sun, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems